EMBC Earnings Date: Nov 24, 2026 (Estimated) — Embecta Corp. Common Stock
XNAS · Healthcare · Medical Instruments & Supplies
Updated
When is EMBC's next earnings date?
Embecta Corp. Common Stock (EMBC) is expected to report Q4 2026 earnings on Tuesday, November 24, 2026 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.31 on revenue of $267.4M.
How did EMBC do in its last earnings report?
In its most recent report on Aug 7, 2026 (Q3 2026), Embecta Corp. Common Stock posted EPS of $0.56 versus the $0.27 estimate, a beat of 115.4%. Revenue was $271.7M against a $254.5M estimate. The stock's 1-day post-earnings move was +26.3%.
How much does EMBC stock move after earnings?
EMBC beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 19.7% (up or down) in the day after earnings.
About Embecta Corp. Common Stock
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 | Q3 2026 | 0.27 | 0.56 | +115.38% | $271.7M | ✅ Beat | +26.28% | +46.01% | +66.05% |
| 2026-05-05 | Q2 2026 | 0.42 | 0.27 | -35.71% | $221.8M | ❌ Miss | -57.84% | -63.67% | -64.00% |
| 2026-02-05 | Q1 2026 | 0.67 | 0.71 | +5.97% | $261.2M | ✅ Beat | -7.73% | -11.36% | -18.92% |
| 2025-11-25 | Q4 2025 | 0.46 | 0.50 | +8.70% | $264.0M | ✅ Beat | -7.20% | -15.95% | -16.37% |
| 2025-08-08 | Q3 2025 | 0.78 | 1.12 | +43.59% | $295.5M | ✅ Beat | +18.58% | +33.89% | +42.86% |
| 2025-02-06 | Q1 2025 | 0.44 | 0.65 | +47.73% | $261.9M | ✅ Beat | -2.59% | -8.64% | -29.16% |
| 2024-11-26 | Q4 2024 | 0.36 | 0.45 | +25.00% | $286.1M | ✅ Beat | +29.77% | +41.74% | +45.62% |
| 2024-08-09 | Q3 2024 | 0.46 | 0.74 | +60.87% | $272.5M | ✅ Beat | +7.37% | +1.67% | +7.98% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q3 FY26 · $57.6M total
| Segment | Share | Revenue | YoY | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|
| Safety | 63.7% | $36.7M | +5.5% | $34.8M | $68.8M | $37.3M | $34.3M |
| Product and Service, Other | 27.1% | $15.6M | +387.5% | $3.2M | $7.5M | $3.6M | $4.0M |
| Manufacturing Facility | 9.2% | $5.3M | -3.6% | $5.5M | $10.0M | $4.1M | $2.5M |
By region
Q3 FY26 · $271.7M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| Non-US | 55.5% | $150.9M | +11.5% | $247.6M | $123.8M | $135.3M | $242.2M |
| UNITED STATES | 44.5% | $120.8M | -24.6% | $311.0M | $135.2M | $160.2M | $283.7M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.